✦ LIBER ✦

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial

✍ Scribed by Marcello Deraco; Shigeki Kusamura; Salvatore Virzì; Francesco Puccio; Antonio Macrì; Ciro Famulari; Massimiliano Solazzo; Serena Bonomi; Domenico Rosario Iusco; Dario Baratti

Book ID: 113963239
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 218 KB
Volume: 122
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.05.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: “Cytoreductive surgery and hyperther

Re: “Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase II trial.” — Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study.

✍ Luca Ansaloni; Pierandrea De Iaco; Luigi Frigerio 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Secondary cytoreductive surgery and hype

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study

✍ M Deraco; S Virzì; DR Iusco; F Puccio; A Macrì; C Famulari; M Solazzo; S Bonomi; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Hyperthermic Intraperitoneal Chemotherap

Hyperthermic Intraperitoneal Chemotherapy After Extensive Cytoreductive Surgery in Patients with Primary Advanced Epithelial Ovarian Cancer: Interim Analysis of a Phase II Study

✍ Myong Cheol Lim; Sokbom Kang; Jaeho Choi; Yong Jung Song; Sohee Park; Sang-Soo S 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 230 KB

Hyperthermic intra-peritoneal chemothera

Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study

✍ C. Pomel; G. Ferron; G. Lorimier; A. Rey; C. Lhomme; J.M. Classe; J.M. Bereder; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 139 KB

A phase III randomized trial of BAY 12-9

A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study

✍ H. Hirte; I.B. Vergote; J.R. Jeffrey; R.N. Grimshaw; S. Coppieters; B. Schwartz; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Gemcitabine and oxaliplatin followed by

Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study

✍ C.B. Steer; K. Chrystal; K.A. Cheong; E. Galani; G.M. Marx; A.H. Strickland; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB